One billion doses and WHO prequalification of nOPV2: Implications for the global polio situation and beyond
Ananda S Bandyopadhyay, Laura Cooper, Simona Zipursky
Abstract
With the COVID-19 pandemic abating, the only remaining Public Health Emergency of International Concern is polio Remarkable progress has been made in reducing the global burden of poliomyelitis since the establishment of the Global Polio Eradication Initiative (GPEI) in 1988. However, achieving and sustaining eradication of all forms of polioviruses is being compromised by two sources of paralytic poliomyelitis: persisting pockets of type 1 wild poliovirus transmission in Afghanistan and Pakistan which reported 6 cases each in 2023 [2] and ongoing outbreaks of circulating vaccine-derived polioviruses (cVDPV) The latter, particularly those arising from type 2 Sabin oral polio vaccine (OPV) strains, have outnumbered cases of wild-type polio over the last few years, mostly due to outbreaks in the WHO African Region which affected 28 different countries in 2023